We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,335.00 | 1,333.50 | 1,334.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.22 | 55.34B |
Date | Subject | Author | Discuss |
---|---|---|---|
12/1/2023 14:54 | What is share doing directionless up in morning and back down in afternoon | mj19 | |
12/1/2023 09:51 | Yes, dividend reached my AJ Bell accounts this morning .... ;0) | tradermichael | |
12/1/2023 09:18 | Divi day today,shares are cheap too. | abdullla | |
11/1/2023 21:30 | This is quite a big move by the US FDA. New medicines need not be tested in animals to receive U.S. Food and Drug Administration (FDA) approval, according to legislation signed by President Joe Biden in late December 2022. The change—long sought by animal welfare organizations— safety regulation. In place of the 1938 stipulation that potential drugs be tested for safety and efficacy in animals, the law allows FDA to promote a drug or biologic—a larger molecule such as an antibody—to human trials after either animal or non-animal tests. It is a very complex area and for example, animal tissue could be used in tox studies - it is just that the animal is dead. | alphorn | |
11/1/2023 12:33 | It's not doing much at the moment. I topped up its at reasonable price. Bought some at £15.20 and now again.. | mj19 | |
11/1/2023 10:15 | Some may be interested. ”GSK plc (GSK) Presents at 41st Annual JPMorgan Healthcare Conference” There is an option to listen to the pitch as well (Press Play Earnings Call button) | geckotheglorious | |
11/1/2023 08:05 | Well, I kept within the Normal Market Size! Good luck. | tradermichael | |
10/1/2023 21:05 | Me too funnily enough, although I suspect you bought a few more than I did ;) | rikky72 | |
10/1/2023 12:47 | IN @ 1415.00 ..... ;0) | tradermichael | |
10/1/2023 12:17 | I hope not diku but wouldn't be surprised to see 13 something soon. | tuftymatt | |
10/1/2023 12:04 | Is this heading back down to 1300 - 1320p?... | diku | |
10/1/2023 12:02 | Normal Market Size (NMS) for GSK on London Exchange is 200,000 | tradermichael | |
10/1/2023 11:13 | Anyone happen to know what the exchange market size is for this? Can't find it where I used to look.. | rikky72 | |
10/1/2023 08:48 | I sold out back then but am in again with a 1418 average. As TM says it has a nice divi and I am sure can tick up from here given time and a bit of positive product / legal news!! | tuftymatt | |
10/1/2023 08:32 | It pays out another nice dividend in 2 days time .... ;0) | tradermichael | |
10/1/2023 08:14 | So regret not selling this dog recently at 1600. | spoole5 | |
09/1/2023 10:56 | Hi all, just giving a second and final push to my blog about GSK, which I am a shareholder in. Feedback welcome and the blog can be found here https://tbifund.word | pdosullivan | |
08/1/2023 14:00 | Hi all. I have written a blog about GSK, which I am a shareholder in, that you may find of interest. The blog can be found here https://tbifund.word | pdosullivan | |
05/1/2023 10:03 | Just the silly downgrade | mj19 | |
05/1/2023 09:52 | Yep! FTSE goes down, GSK goes down. FTSE goes up, GSK goes down.. rinse and repeat until hell freezes over.. | rikky72 | |
05/1/2023 09:30 | GSK : JP Morgan cuts target price to 1,350p from 1,600p * GSK : JP Morgan cuts to underweight from neutral | mj19 | |
05/1/2023 09:26 | Alliance News: IN BRIEF: WuXi Biologics signs exclusive deal with GSK Thu, 5th Jan 2023 09:05 WuXi Biologics Inc - China-based contract research, development & manufacturing organisation, offering end-to-end biologics solutions - Enters into a license deal with GSK PLC for one preclinical bi-specific T cell engaging antibody and the option of three additional bi- & multi-specific TCE antibodies developed using WuXi Biologics' proprietary technology platforms. Says WuXi Biologics will get an upfront payment of USD40 million and tiered royalties on net sales. WuXi Biologics Chief Executive Officer Chris Chen says: "We are looking forward to enabling GSK to bring these potentially life-saving therapeutics to more patients worldwide." WuXi Biologics current stock price: HKD67.50 12-month change: down 14% GSK current stock price: 1,427.60 pence, down 1.4% on Thursday morning in London 12-month change: down 12% | estienne | |
05/1/2023 09:25 | Just gsk being gsk! | spoole5 | |
05/1/2023 09:21 | Do we know why GSK is going down while more or less the entire FTSE100 is going up? Is there some bad news broken somewhere that is not common knowledge? | netcurtains |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions